Investment Summary |
|
|---|---|
| Date | 2020-11-19 |
| Target | SynOx Therapeutics |
| Sector | Life Science |
| Investor(s) | GIMV |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 139 of 170 |
| Sector: Life Science M&A | 20 of 24 |
| Type: Venture M&A Deals | 36 of 39 |
| Country: Ireland M&A | 3 of 3 |
| Year: 2020 M&A | 7 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-20 |
Melijoe
Paris, France Melijoe is a an online children's fashion store. Melijoe was founded in 2007 and is based in Paris, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-30 |
Kinaset Therapeutics
Boston, Massachusetts, United States Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. Kinaset Therapeutics was founded in 2020 and is based in Boston, Massachusetts. |
Buy | - |
